Involved in the "first major bidding case of national procurement", ApicHope Pharmaceutical may face its first loss after going public | Interpretations

① Due to the continued increase in research and development investment, reimbursement of medical insurance refunds, and other factors, ApicHope Pharmaceutical may experience its first loss since its listing in 2024. ② It is expected that the net loss in Q4 will be between 0.225 billion yuan and 0.433 billion yuan.

cls.cnJan 22 10:27 ET

Shenzhen Kangtai Biological Products: Expected net income to decrease by about 70% last year, adjustments to the immunization program may lead to a decrease in sales of the tetravalent vaccine | Interpretations

In 2024, affected by market competition, inventory reduction and other factors, Shenzhen Kangtai Biological Products expects Net income to decline by about 70% year-on-year; fixed asset depreciation expenses and increased asset impairment have also impacted the company's Net income decline; recent adjustments by the government to the immunization schedule for DTP vaccines may lead to a risk of declining sales for the company's four-component vaccine products.

cls.cnJan 22 10:26 ET

Montage Technology's net profit for 2024 is expected to increase by over 200%. In Q4, multiple data points hit record highs, driven by the AI boom, leading to new product shipments.

Montage Technology expects to achieve a net income of 1.378 billion to 1.438 billion yuan for the fiscal year 2024, representing year-on-year growth of 205.62% to 218.93%; The company announced the launch of its latest developed PCIe 6.x/CXL 3.x Retimer chip, which has been successfully delivered to customers for sampling.

cls.cnJan 22 10:01 ET

Wuhan Guide Infrared reports its first loss since going public, with a Q4 expected loss exceeding 0.4 billion yuan | Interpretations

① After three consecutive years of performance pressure, Wuhan Guide Infrared experienced its first annual loss since its listing; ② It is expected that the company's losses in Q4 will exceed 0.4 billion yuan.

cls.cnJan 22 09:13 ET

Stopping federal funding, reducing loans and subsidies, Trump "strikes hard" against Shanxi Guoxin Energy Corporation!

After the inauguration ceremony, Trump signed dozens of executive orders, including a suspension of federal grants to manufacturers and infrastructure developers, which could jeopardize over $300 billion in potential federal infrastructure funding. He also announced plans to halt the construction of wind farms on federal lands and waters, as well as to end 'unfair subsidies' for electric vehicles, causing the stock prices of several electric vehicle and wind power companies to decline.

wallstreetcnJan 22 06:54 ET

A value-added rate of 2181.35%! Nanchip Technology plans to acquire 100% equity of Shengshengwei for no more than 0.16 billion yuan, focusing on the MCU chip Business.

1. Nanchip Technology stated that this acquisition is part of a strategy to "horizontally expand the product categories," adding the MUC chip business to its existing embedded chip foundation; 2. This acquisition was assessed using the market method, with Shengshengwei's evaluation of total equity attributable to the parent company's Shareholders being 0.161 billion yuan, an increase of 0.154 billion yuan, representing a growth rate of 2181.35%.

cls.cnJan 22 00:11 ET